Anzeige
❌
Mehr »
Sonntag, 22.11.2026 - Börsentäglich über 12.000 News
Zufall oder Strategie? Copper One zündet die nächste Stufe seiner Kupfer-Offensive!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Pharmaceutical Technology

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
21.10.Sanofi and ScionxBio partner on mRNA therapies
20.10.EyePoint halves workforce and ends Phase III trial early after endpoint miss
20.10.Merck KGaA spends $1.3bn to buy siRNA specialist Silence Therapeutics
20.10.Ambrose Healthcare fortifies rare disease pipeline on AM-Pharma takeover
19.10.Roche's Enspryng nets a second indication on FDA eye disease approval
19.10.MHRA could allow schools to hold reserves of nasal adrenaline spray
19.10.FDA approves Viatris' Ryzumvi for adult presbyopia
19.10.Estuary secures $103m to advance kidney disease gene therapies
16.10.Lilly's Foundayo wins EMA panel backing for obesity and type 2 diabetes
16.10.OrbiMed raises $3bn to back global life science players
16.10.AstraZeneca and insitro forge $1.5bn AI-powered cardiometabolic partnership
16.10.Acta Pharmaceuticals raises $24m for Alzheimer's therapies
16.10.Transcripta Bio, Mayo Clinic join force on ALS therapies
15.10.Gilead and Vir forge $1.9bn pact to develop next-gen T-cell engagers
15.10.Rare disease regulation reaches "inflection point" with new FDA framework
15.10.QCi and INmune Bio partner to study XPro in Alzheimer's
15.10.ImmunityBio's bladder cancer drug, Anktiva lands US label expansion
15.10.Alentis and PinotBio partner to develop claudin-1 oncology ADCs
14.10.Zealand Pharma pens $1.2bn AI obesity drug discovery pact with Generate
14.10.MHRA homes in on personalised healthcare and tech in new 2030 strategy
14.10.Charles River partners with Magellan Stem Cells on cell therapy
14.10.Pfizer partners with Enodia Therapeutics in $500m drug deal
13.10.Tremfya rescues J&J's immunology sales to fuel strong Q3
13.10.China's NMPA clears Foresee's Camcevi 42 mg for prostate cancer
13.10.Southern Research secures NIH funding for drug testing hub